ArticleOne health (Amsterdam, Netherlands)2025
Molecular detection and characterization of methicillin-resistant
Article in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Isolation of a Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2026Article
- Comparative phylogenetic, antimicrobial resistance, and clinical characterization of human spondylodiscitis-associatedFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: Nasal swabs from healthcare workers ( Results: Two MRSP isolates (ST2361) were identified, one from a nasal swab and another from hospital supplies. Both exhibited resistance to β-lactams (cefoxitin, penicillin), fluoroquinolones, macrolides, and sulfonamide-trimethoprim, but susceptibility to tetracyclines, gentamicin, linezolid, and vancomycin. PCR confirmed Conclusion: The presence of MRSP ST2361 in humans and hospital environments highlights its zoonotic and nosocomial transmission risks. The isolates' multidrug resistance and virulence genes underscore the need for improved diagnostics, antimicrobial stewardship, and infection control measures in healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.